Search results
SageView Advisory Group LLC Acquires 718 Shares of Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 7 days agoSageView Advisory Group LLC boosted its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 30.6% in the fourth quarter, according to the company in its most recent ...
Novartis stock rated 'Buy' by Goldman Sachs, highlighting robust innovation By Investing.com
Investing.com· 5 days agoOn Thursday, Goldman Sachs (NYSE:GS) initiated coverage on Novartis AG (SIX:NOVN) stock, listed as...
Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
Zacks via Yahoo Finance· 3 days agoNovartis NVS announced new long-term efficacy and safety data from the late-stage studies REMIX-1...
Goldman Sachs initiates cover on six European pharma stocks By Investing.com
Investing.com· 5 days agoGoldman Sachs initiates cover on six European pharma stocks
Exploring Three Swiss Dividend Stocks With Yields Up To 3.9%
Simply Wall St. via Yahoo Finance· 23 hours agoThe Switzerland market demonstrated robust performance recently, concluding a notably strong session...
Health Care Roundup: Market Talk
The Wall Street Journal· 4 days agoShares of the three pharma giants closed 1% higher. (helena.smolak@wsj.com) 1133 ET – Roche’s earnings are...Innovation catalyzers for the Swiss...
Goldman Sachs Says Buy European Pharma Stocks Touting Innovation
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have...
Asahi Kasei to Buy Swedish Biotech for Rare Disease Drug
Bloomberg via Yahoo Finance· 7 days ago(Bloomberg) -- Japanese industrial group Asahi Kasei Corp. plans to buy Swedish biotechnology firm...
Exploring Three Japanese Growth Companies With High Insider Ownership On The Tokyo Stock Exchange
Simply Wall St. via Yahoo Finance· 5 days agoAmid a backdrop of fluctuating global markets, with Japan's Nikkei 225 experiencing slight declines...
Campbell hires lawyer to head affordability unit - The Boston Globe
The Boston Globe· 6 days agoA former longtime executive at the Swiss drug giant Novartis will become the new chief executive of...
